IL17A and disease of the tendon: Together these findings suggest that upregulation of the receptor ligand IL-17A is the key driver to boost signal induction in tendinopathy and that IL-17A is the main IL-17 cytokine family member contributing to the pathogenesis of human early-stage tendinopathy.